Next Article in Journal
Neuropathic Pain Treatment: Still a Challenge
Previous Article in Journal
Frontotemporal Dementia in Amyotrophic Lateral Sclerosis: From Rarity to Reality?
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Neurology International
Volume 8
Issue 2
10.4081/ni.2016.6617
neurolint-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Neurology International is published by MDPI from Volume 12 Issue 3 (2020). Previous articles were published by another publisher in Open Access under a CC-BY licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke can Cause Inferior Myocardial Infarction?

by
Mostafa Almasi
,
Saeed Razmeh
*,
Amir Hassan Habibi
and
Amir Hassan Rezaee
Department of Neurology, Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
*
Author to whom correspondence should be addressed.
Neurol. Int. 2016, 8(2), 6617; https://doi.org/10.4081/ni.2016.6617
Submission received: 22 May 2016 / Revised: 22 May 2016 / Accepted: 30 May 2016 / Published: 29 June 2016

Abstract

Recombinant tissue plasminogen activator (rTPA) is one of the main portions of acute ischemic stroke management, but unfortunately has some complications. Myocardial infarction (MI) is a hazardous complication of administration of intravenous rTPA that has been reported recently. A 78-year-old lady was admitted for elective coronary artery bypass graft surgery. On the second day of admission, she developed acute left hemiparesis and intravenous rTPA was administered within 120 minutes. Three hours later, she has had chest pain. Rescue percutaneous coronary intervention was performed on right coronary artery due to diagnosis of inferior MI, and the symptoms were resolved.
Keywords: Recombinant tissue plasminogen activator; Myocardial infarction; Acute ischemic stroke Recombinant tissue plasminogen activator; Myocardial infarction; Acute ischemic stroke

Share and Cite

MDPI and ACS Style

Almasi, M.; Razmeh, S.; Habibi, A.H.; Rezaee, A.H. Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke can Cause Inferior Myocardial Infarction? Neurol. Int. 2016, 8, 6617. https://doi.org/10.4081/ni.2016.6617

AMA Style

Almasi M, Razmeh S, Habibi AH, Rezaee AH. Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke can Cause Inferior Myocardial Infarction? Neurology International. 2016; 8(2):6617. https://doi.org/10.4081/ni.2016.6617

Chicago/Turabian Style

Almasi, Mostafa, Saeed Razmeh, Amir Hassan Habibi, and Amir Hassan Rezaee. 2016. "Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke can Cause Inferior Myocardial Infarction?" Neurology International 8, no. 2: 6617. https://doi.org/10.4081/ni.2016.6617

APA Style

Almasi, M., Razmeh, S., Habibi, A. H., & Rezaee, A. H. (2016). Does Intravenous Administration of Recombinant Tissue Plasminogen Activator for Ischemic Stroke can Cause Inferior Myocardial Infarction? Neurology International, 8(2), 6617. https://doi.org/10.4081/ni.2016.6617

Article Metrics

Back to TopTop